Aramis Biotechnologies is based in Quebec City, Quebec, Canada. It has raised $30M in total funding. Latest round: Series A.
Aramis Biotechnologies is based in Quebec City, Quebec, Canada. Aramis Biotechnologies has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Aramis Biotechnologies runs through 2024; nothing later has been disclosed. Investors on record include Employees, Private Investors, Government of Canada (Strategic Innovation Fund). 3 distinct backers are named across the disclosed rounds.
Aramis Biotechnologies totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Quebec City below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026